Pharmacological Inhibitors of Fatty Acid Synthase (FASN)-Catalyzed Endogenous Fatty Acid Biogenesis: A New Family of Anti-Cancer Agents?
|
journal
|
December 2006 |
Modulation of breast cancer progression and differentiation by thegp30/neregulin
|
journal
|
January 1994 |
Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research
|
journal
|
October 2016 |
Metabolic alterations and targeted therapies in prostate cancer
|
journal
|
November 2010 |
Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells
|
journal
|
July 2006 |
Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Complexes by MMP-2 Proteolysis
|
journal
|
December 2007 |
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
|
journal
|
May 2015 |
The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration
|
journal
|
August 2007 |
Antiangiogenic Therapies: Going beyond Their Limits
|
journal
|
January 2014 |
Sterol Regulatory Element-Binding Protein–1/Fatty Acid Synthase Involvement in Proliferation Inhibition and Apoptosis Promotion Induced by Progesterone in Endometrial Cancer
|
journal
|
November 2013 |
Molecularly targeted therapies for metastatic triple-negative breast cancer
|
journal
|
January 2013 |
Lipogenesis in cancer progression (Review)
|
journal
|
May 2014 |
αVβ3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer
|
journal
|
March 2005 |
Functional domains of CCN1 (Cyr61) regulate breast cancer progression
|
journal
|
July 2008 |
The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
|
journal
|
June 2003 |
The nutritional phenome of EMT-induced cancer stem-like cells
|
journal
|
June 2014 |
Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway
|
journal
|
October 2000 |
CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth
|
journal
|
May 1998 |
Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
|
journal
|
March 2012 |
Fatty acid synthase as a potential therapeutic target in cancer
|
journal
|
April 2010 |
An Angiogenic Switch in Breast Cancer Involves Estrogen and Soluble Vascular Endothelial Growth Factor Receptor 1
|
journal
|
June 2004 |
Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding proteins
|
journal
|
November 1997 |
P2-05-01: Acquired Tamoxifen Resistance Promotes Angiogenic Responses in ER+ Breast Cancer Cells.
|
journal
|
December 2011 |
Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells.
|
journal
|
December 1992 |
Breast Cancer
|
journal
|
April 2001 |
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
|
journal
|
October 2007 |
Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives
|
journal
|
March 2010 |
Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids
|
journal
|
October 2013 |
CCN proteins and cancer: two to tango
|
journal
|
January 2005 |
A novel CYR61-triggered ‘CYR61-αvβ3 integrin loop’ regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway
|
journal
|
December 2004 |
Cyr61 promotes breast tumorigenesis and cancer progression
|
journal
|
November 2002 |
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
|
journal
|
October 2003 |
Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development
|
journal
|
June 2003 |
Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance
|
journal
|
February 2009 |
Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer
|
journal
|
March 2012 |
Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
|
journal
|
January 2012 |
Vascular Endothelial Growth Factor Secreted by Activated Stroma Enhances Angiogenesis and Hormone-Independent Growth of Estrogen Receptor–Positive Breast Cancer
|
journal
|
March 2010 |
Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer
|
journal
|
February 2014 |
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
|
journal
|
December 2011 |
Androgens Stimulate Lipogenic Gene Expression in Prostate Cancer Cells by Activation of the Sterol Regulatory Element-Binding Protein Cleavage Activating Protein/Sterol Regulatory Element-Binding Protein Pathway
|
journal
|
October 2001 |
Expression and regulation of Cyr61 in human breast cancer cell lines
|
journal
|
January 2002 |
Identification of a Novel Integrin αvβ3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells
|
journal
|
October 2004 |
Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal
|
journal
|
August 2014 |
Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c
|
journal
|
January 2003 |
Triple-negative breast cancer: disease entity or title of convenience?
|
journal
|
September 2010 |
The Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts
|
journal
|
December 2001 |
Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165
|
journal
|
September 2002 |
Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion
|
journal
|
April 1996 |
Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin α
v
β
3
, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo
|
journal
|
April 1999 |
Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1
|
journal
|
February 2008 |
Cytokine Receptor CXCR4 Mediates Estrogen-Independent Tumorigenesis, Metastasis, and Resistance to Endocrine Therapy in Human Breast Cancer
|
journal
|
January 2011 |
New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity
|
journal
|
February 2014 |
Molecular Pathways: Fatty Acid Synthase
|
journal
|
December 2015 |
Enhancement of vascular endothelial growth factor–mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression
|
journal
|
August 2009 |
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
|
journal
|
July 2011 |
Triple-Negative Breast Cancer: An Unmet Medical Need
|
journal
|
January 2011 |